Advanced search
Publication Cover
Journal of Inflammation Research Volume 16, 2023 - Issue
Submit an article Journal homepage
203
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ge-Gen Decoction Exerts an Anti-Primary Dysmenorrhea Effect in Rats by Inactivating the HSP90/NLRP3/NF-κB/COX-2 Pathway

Yazhen Xie1 Department of Gynaecology, Taicang Traditional Chinese Medicine Hospital, Affiliated to Nanjing University of Chinese Medicine, Taicang, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8198-2349
ORCID Icon &
Jianqiang Qian2 Department of Traditional Chinese Medicine, Taicang Traditional Chinese Medicine Hospital, Affiliated to Nanjing University of Chinese Medicine, Taicang, People’s Republic of China
Pages 1571-1580 | Received 07 Dec 2022, Accepted 05 Apr 2023, Published online: 15 Apr 2023

References

  • Ferries-Rowe E, Corey E, Archer JS. Primary dysmenorrhea: diagnosis and therapy. Obstet Gynecol. 2020;136(5):1047–1058. doi:10.1097/AOG.0000000000004096
  • Feng X, Wang X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis. Mol Pain. 2018;14:1744806918770320. doi:10.1177/1744806918770320
  • Leem J, Jo J, Kwon CY, Lee H, Park KS, Lee JM. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2019;98(5):e14170. doi:10.1097/MD.0000000000014170
  • Li N, Li J, Gai P. Effects of modified wenjing decoction combined with online publicity and education on the treatment of primary dysmenorrhea of cold coagulation and blood stasis. J Healthc Eng. 2022;2022:1899356.
  • Ma C, Liang N, Gao L, Jia C. Danggui Sini Decoction (herbal medicine) for the treatment of primary dysmenorrhoea: a systematic review and meta-analysis. J Obstet Gynaecol. 2021;41(7):1001–1009. doi:10.1080/01443615.2020.1820461
  • Li G, Zhang Z, Zhou L, et al. Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial. Trials. 2021;22(1):95. doi:10.1186/s13063-021-05050-w
  • Yang L, Chai CZ, Yue XY, et al. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy. Chin J Nat Med. 2016;14(2):124–132. doi:10.1016/S1875-5364(16)60005-5
  • Chai C, Hong F, Yan Y, et al. Effect of traditional Chinese medicine formula GeGen decoction on primary dysmenorrhea: a randomized controlled trial study. J Ethnopharmacol. 2020;261:113053. doi:10.1016/j.jep.2020.113053
  • Yu WY, Ma LX, Zhang Z, et al. Acupuncture for primary dysmenorrhea: a potential mechanism from an anti-inflammatory perspective. Evid Based Complement Alternat Med. 2021;2021:1907009. doi:10.1155/2021/1907009
  • Szmidt MK, Granda D, Sicinska E, Kaluza J. Primary dysmenorrhea in relation to oxidative stress and antioxidant status: a systematic review of case-control studies. Antioxidants. 2020;9(10). doi:10.3390/antiox9100994
  • Tang B, Liu D, Chen L, Liu Y. NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-kappaB/COX-2/PG pathway. J Inflamm. 2020;17:22. doi:10.1186/s12950-020-00251-7
  • Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653–668. doi:10.1016/j.tips.2022.04.003
  • Xie Y, Qian J, Lu Q. The therapeutic effect of ge-gen decoction on a rat model of primary dysmenorrhea: label-free quantitative proteomics and bioinformatic analyses. Biomed Res Int. 2020;2020:5840967. doi:10.1155/2020/5840967
  • Hoter A, El-Sabban ME, Naim HY. The HSP90 family: structure, regulation, function, and implications in health and disease. Int J Mol Sci. 2018;19(9):2560. doi:10.3390/ijms19092560
  • Nizami S, Arunasalam K, Green J, et al. Inhibition of the NLRP3 inflammasome by HSP90 inhibitors. Immunology. 2021;162(1):84–91. doi:10.1111/imm.13267
  • Xu G, Fu S, Zhan X, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6(2). doi:10.1172/jci.insight.134601
  • Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
  • Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(9):688. doi:10.1038/nrd.2018.149
  • Piippo N, Korhonen E, Hytti M, et al. Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome. Sci Rep. 2018;8(1):6720. doi:10.1038/s41598-018-25123-2
  • Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-kappaB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757–775. doi:10.1016/j.it.2022.07.004
  • Chen Y, Cao Y, Xie Y, et al. Traditional Chinese medicine for the treatment of primary dysmenorrhea: how do Yuanhu painkillers effectively treat dysmenorrhea? Phytomedicine. 2013;20(12):1095–1104. doi:10.1016/j.phymed.2013.05.003
  • Zhang Y, Su N, Liu W, Wang Q, Sun J, Peng Y. Metabolomics study of Guizhi Fuling capsules in rats with cold coagulation dysmenorrhea. Front Pharmacol. 2021;12:764904. doi:10.3389/fphar.2021.764904
  • Hong F, He G, Zhang M, Yu B, Chai C. The establishment of a mouse model of recurrent primary dysmenorrhea. Int J Mol Sci. 2022;23(11):6128. doi:10.3390/ijms23116128

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.